Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Datti

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2016
Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of GlioblastomaXueqing Lun, J Connor Wells, Natalie Grinshtein, et al.
The Journal of Clinical Investigation|August 30, 2016
RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translationRobert A Jones, Tyler J Robinson, Jeff C Liu, et al.
Plos One|September 24, 2020
Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer modelsNicole Pinto, Stephenie D Prokopec, Farhad Ghasemi, et al.
The EMBO Journal|January 13, 2022
Hypophosphorylated pRb knock-in mice exhibit hallmarks of aging and vitamin C-preventable diabetesZhe Jiang, Huiqin Li, Stephanie A Schroer, et al.
Cancer Research|June 17, 2015
Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell DeathEric A Lee, Leonard Angka, Sarah-Grace Rota, et al.
Oncotarget|October 27, 2017
Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancerFarhad Ghasemi, Morgan Black, Frederick Vizeacoumar, et al.
Science Translational Medicine|January 29, 2011
Uroporphyrinogen decarboxylase is a radiosensitizing target for head and neck cancerEmma Ito, Shijun Yue, Eduardo H Moriyama, et al.
Blood|May 27, 2008
Cyproheptadine displays preclinical activity in myeloma and leukemiaXinliang Mao, Sheng-ben Liang, Rose Hurren, et al.
Genes & Development|April 17, 2015
Myc and SAGA rewire an alternative splicing network during early somatic cell reprogrammingCalley L Hirsch, Zeynep Coban Akdemir, Li Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphomaRashmi S Goswami, Eshetu G Atenafu, Yali Xuan, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2016
Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of GlioblastomaXueqing Lun, J Connor Wells, Natalie Grinshtein, et al.
The Journal of Clinical Investigation|August 30, 2016
RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translationRobert A Jones, Tyler J Robinson, Jeff C Liu, et al.
Plos One|September 24, 2020
Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer modelsNicole Pinto, Stephenie D Prokopec, Farhad Ghasemi, et al.
The EMBO Journal|January 13, 2022
Hypophosphorylated pRb knock-in mice exhibit hallmarks of aging and vitamin C-preventable diabetesZhe Jiang, Huiqin Li, Stephanie A Schroer, et al.
Cancer Research|June 17, 2015
Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell DeathEric A Lee, Leonard Angka, Sarah-Grace Rota, et al.
Oncotarget|October 27, 2017
Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancerFarhad Ghasemi, Morgan Black, Frederick Vizeacoumar, et al.
Science Translational Medicine|January 29, 2011
Uroporphyrinogen decarboxylase is a radiosensitizing target for head and neck cancerEmma Ito, Shijun Yue, Eduardo H Moriyama, et al.
Blood|May 27, 2008
Cyproheptadine displays preclinical activity in myeloma and leukemiaXinliang Mao, Sheng-ben Liang, Rose Hurren, et al.
Genes & Development|April 17, 2015
Myc and SAGA rewire an alternative splicing network during early somatic cell reprogrammingCalley L Hirsch, Zeynep Coban Akdemir, Li Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphomaRashmi S Goswami, Eshetu G Atenafu, Yali Xuan, et al.
Pageof 9